Shingrix (Zostavax) Market

Table Of Content

Executive Summary
1. Introduction
Market Introduction
1. Market Definition
2. Scope of the Study
3. Market Structure
Research Methodology
1. Primary Research
2. Research Methodology
3. Assumptions & Exclusions
4. Secondary Data Sources
Market Factor Analysis
1. Value Chain Analysis: Shingrix Zostavax Market
2. Porters Five Forces Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of Substitution
  4. Threat of New Entrants
  5. Competitive Rivalry
Market Dynamics
1. Drivers
2. Restraints
3. Opportunities
Recent Trends Analysis
Impact of COVID-19 on Shingrix Zostavax Market
1. Pre and Post Covid -19 Market Scenario Analysis
2. Market Recovery Timeline and Challenge
3. Measures Taken by Top Players
Regulatory Landscape
Shingrix Zostavax Market, By Vaccine Type
1. Introduction
  1. Market Size and Forecast, By Vaccine Type
2. Recombinant Vaccine (Shingrix)
  1. Market Size and Forecast, By Region
3. Live-Attenuated Vaccine (Zostavax)
  1. Market Size and Forecast, By Region
Shingrix Zostavax Market, By Indication
1. Introduction
  1. Market Size and Forecast, By Indication
2. Shingles Prevention
  1. Market Size and Forecast, By Region
3. Post-Herpetic Neuralgia (PHN)
  1. Market Size and Forecast, By Region
Shingrix Zostavax Market, By Distribution Channel
1. Introduction
  1. Market Size and Forecast, By Distribution Channel
2. Hospital Pharmacies
  1. Market Size and Forecast, By Region
3. Retail Pharmacies
  1. Market Size and Forecast, By Region
4. Online Pharmacies
  1. Market Size and Forecast, By Region
5. Others
  1. Market Size and Forecast, By Region
Regional Overview
1. Introduction
  1. Market Size and Forecast
2. North America
  1. Market Size and Forecast
    1. By Vaccine Type
      1. Recombinant Vaccine (Shingrix)
      2. Live-Attenuated Vaccine (Zostavax)
    2. By Indication
      1. Shingles Prevention
      2. Post-Herpetic Neuralgia (PHN)
    3. By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
  2. U.S.
    1. By Vaccine Type
      1. Recombinant Vaccine (Shingrix)
      2. Live-Attenuated Vaccine (Zostavax)
    2. By Indication
      1. Shingles Prevention
      2. Post-Herpetic Neuralgia (PHN)
    3. By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
  3. Canada
3. Europe
  1. Market Size and Forecast
    1. By Vaccine Type
      1. Recombinant Vaccine (Shingrix)
      2. Live-Attenuated Vaccine (Zostavax)
    2. By Indication
      1. Shingles Prevention
      2. Post-Herpetic Neuralgia (PHN)
    3. By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
  2. U.K.
    1. By Vaccine Type
      1. Recombinant Vaccine (Shingrix)
      2. Live-Attenuated Vaccine (Zostavax)
    2. By Indication
      1. Shingles Prevention
      2. Post-Herpetic Neuralgia (PHN)
    3. By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
  3. Germany
  4. France
  5. Spain
  6. Italy
  7. Russia
  8. Nordic
  9. Benelux
  10. Rest of Europe
4. APAC
  1. Market Size and Forecast
    1. By Vaccine Type
      1. Recombinant Vaccine (Shingrix)
      2. Live-Attenuated Vaccine (Zostavax)
    2. By Indication
      1. Shingles Prevention
      2. Post-Herpetic Neuralgia (PHN)
    3. By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
  2. China
    1. By Vaccine Type
      1. Recombinant Vaccine (Shingrix)
      2. Live-Attenuated Vaccine (Zostavax)
    2. By Indication
      1. Shingles Prevention
      2. Post-Herpetic Neuralgia (PHN)
    3. By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
  3. Korea
  4. Japan
  5. India
  6. Australia
  7. Singapore
  8. Taiwan
  9. South East Asia
  10. Rest of Asia-Pacific
5. Middle East and Africa
  1. Market Size and Forecast
    1. By Vaccine Type
      1. Recombinant Vaccine (Shingrix)
      2. Live-Attenuated Vaccine (Zostavax)
    2. By Indication
      1. Shingles Prevention
      2. Post-Herpetic Neuralgia (PHN)
    3. By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
  2. UAE
    1. By Vaccine Type
      1. Recombinant Vaccine (Shingrix)
      2. Live-Attenuated Vaccine (Zostavax)
    2. By Indication
      1. Shingles Prevention
      2. Post-Herpetic Neuralgia (PHN)
    3. By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
  3. Turky
  4. Saudi Arabia
  5. South Africa
  6. Egypt
  7. Nigeria
  8. Rest of MEA
6. LATAM
  1. Market Size and Forecast
    1. By Vaccine Type
      1. Recombinant Vaccine (Shingrix)
      2. Live-Attenuated Vaccine (Zostavax)
    2. By Indication
      1. Shingles Prevention
      2. Post-Herpetic Neuralgia (PHN)
    3. By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
  2. Brazil
    1. By Vaccine Type
      1. Recombinant Vaccine (Shingrix)
      2. Live-Attenuated Vaccine (Zostavax)
    2. By Indication
      1. Shingles Prevention
      2. Post-Herpetic Neuralgia (PHN)
    3. By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
  3. Mexico
  4. Argentina
  5. Chile
  6. Colombia
  7. Rest of LATAM
Competitive Landscape, 2024
1. Introduction
2. Shingrix Zostavax Market Share Analysis, 2024 (%)
  1. Market Share Analysis, 2024
  2. Competition Ranking, 2024
  3. Key Developments & Growth Strategies
    1. Merger & Acquisition
    2. Product Launch
    3. Expansion
  4. Consolidated SWOT Analysis of Key Players
Company Profile
1. GSK plc
  1. Business Overview
  2. Financial Data
  3. Key Product Categories
  4. Recent Developments
2. Cipla Inc.
3. GlaxoSmithKline
4. Merck
5. SK Chemicals
6. Moderna
7. Green Cross Corp
8. Geneone Life Science
9. Vaccitech
10. CanSinoBIO
11. Pfizer Inc.
12. others

	


A PHP Error was encountered

Severity: Warning
Message:  Undefined array key "list_tbl_fig"
Filename: reports/toc.php
Line Number: 79


	Backtrace:
	
		
	
		
	
		
			
			File: /var/www/html/application/views/frontend/reports/toc.php

			Line: 79

			Function: _error_handler			

		
	
		
	
		
	
		
			
			File: /var/www/html/application/controllers/Web.php

			Line: 215

			Function: view			

		
	
		
	
		
			
			File: /var/www/html/index.php

			Line: 316

			Function: require_once

Check Discount

Get Free Sample

Buy Now

Key Topics Covered

Market Factors (Including Drivers and Restraint)
Market Trends
Market Estimates and Forcasts
Competitive Analysis
Future Market Opportunities

Shingrix (Zostavax) Market Size, Share & Trends Analysis By Vaccine Type (Recombinant Vaccine (Shingrix), Live-Attenuated Vaccine (Zostavax)), By Indication (Shingles Prevention, Post-Herpetic Neuralg. . . . .

Table Of Content

A PHP Error was encountered